Adhesys Medical gets CE mark for its topical skin adhesive for surgical use

Adhesys Medical grabs CE mark for its innovative surgical wound adhesive.

Adhesys Medical, a surgical adhesive company, said it has received a CE mark for its Mar-Cutis Flix topical skin adhesive for surgical use.

The adhesive is a polyurethane-based technology the company said is an innovative alternative to traditional wound closing techniques that features bonding strength, fast sealing and high flexibility.

Adhesys was a U.S.-based medical device startup that was acquired by Germany’s Grünenthal Group last April.

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.

"Having obtained the CE-Certification, we are now looking forward to further developing our technology platform and expanding the possible fields of application,” Klaus-Dieter Langner, chief scientific officer for Grünenthal, said in a statement.

Grünenthal is a pharmaceutical and medical device R&D company with subsidiaries and affiliates in Europe, the U.S. and Latin America and about 5,500 employees. The privately held company reported 2016 revenue of about $1.7 billion.